Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ApiJect Systems America has been awarded an HHS-DOD Title 3, DPA contract to accelerate the building of a new U.S.-based, high-speed, population-scale emergency drug injection capability with prefilled syringes from its subsidiary RAPID USA Inc.
read more
Wednesday, April 13, 2022
ApiJect Systems, Corp. announced the launch of the ApiJect Technology Development Center in greater Orlando, FL.
read more
Tuesday, December 22, 2020
Aprecia is partnering with Battelle to accelerate and expand its advanced capabilities in 3DP pharmaceutical manufacturing.
read more
Friday, February 21, 2020
Purdue University's College of Pharmacy and Aprecia Pharmaceuticals are launching a comprehensive collaboration on future 3DP pharmaceutical equipment and medications.
read more
Aptamer Group, the developer of diagnostic and therapeutic Optimer™ reagents, announced that it has signed an agreement with the multinational pharmaceutical and biopharmaceutical company Takeda Pharmaceutical Company Limited (“Takeda”).
read more
Aptamer Group announced a commercial partnership with Mologic, a developer and manufacturer of lateral flow and rapid diagnostic tests.
read more
Thursday, September 08, 2022
Aptar Pharma has acquired Metaphase Design Group, a leader in applying the science of human factors engineering and ergonomics to product design.
read more
Aptuit LLC announced that the company has innovated a translational strategy that represents a unique approach, known as “Complementary Vision,” for those in search of high value Chemistry, Manufacturing and Control (CMC) services.
read more
Greenwich, CT, March 15, 2012 - Timothy C. Tyson, Aptuit Chairman, announced that effective immediately, Stuart E. Needleman has been named President and Chief Operating Officer of Aptuit LLC. Following the recent sale of the company’s Clinical ...
read more
Thursday, October 20, 2022
Aragen announced that it will operationalize its formulation manufacturing facility in the Mallapur campus, Hyderabad, India by January 2023. The 12,000 square feet new facility will strengthen the company’s ability to deliver clinical supplies to ...
read more
Aragen Life Sciences, formerly known as GVK Biosciences and a leading contract research, development and manufacturing organization, officially marked its transition to a new brand identity. With a legacy of over 20 years of partnering with innovator...
read more
Thursday, December 19, 2024
Aramis Biotechnologies Inc. and Biodextris Inc. announced a strategic partnership that will leverage the expertise of both companies to ensure efficient downstream manufacturing of clinical materials for Aramis' leading product candidate, a seasonal ...
read more
Aravive and WuXi Biologics announced a strategic collaboration agreement granting Aravive the right to use the proprietary WuXiBody™ platform to develop high-affinity bispecific antibodies for a target implicated in cancer and fibrosis.
read more
Archimica has started the operation of its expanded development laboratories at its Lodi (Italy) site. This recent $1.6 Million investment has more than doubled the company's capabilities to realize API and GMP Building Block custom process ...
read more
Archimica has started the operation of its expanded multi-purpose manufacturing capacity at its Lodi (Italy) site. Recent investment has added significantly to the company´s capabilities overall 170 m3 highly flexible reactor capacity to realize API ...
read more